reSee.it - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
" Cancer? Cancer, you know, we're we're seeing certain cases here and there." "for those three cases, you know, there was success. You know, I know two of the patients." "it's not for everybody." "why is it again that some patients are improving with high dosages of mebendazole, ivermectin, etcetera, and some patients are not?" "we did fecal transplant using her grandson, and we extended her life. She improved her appetite." "She improved her hemoglobin, but it wasn't continuous." "we've shown that loss of bifidobacteria is a problem in invasive cancer." "I think there's gonna be in a future where we're gonna have, every cancer is gonna have a microbe attached to it." "Think about HPV cervical cancer, H. Pylori, gastric cancer, Burkitt's lymphoma, Epstein Barr virus." "there's gonna be a link to a cancer and a microbe that's lacking that needs to be repopulated." "in other words, is it over is the tumor growing because of a microbe that's in there that’s allowing it to grow?" "suppression of that microbe would be first to to kill off the tumor." "the methods that we have right now at killing the tumor is we kill off everything. Kind of like what we do with hydroxychloroquine." "We kill off the virus, but then we kill the whole microbiome." "that's not necessarily a solution because the problem is, well, you've killed the virus this time, but then what happens now you've killed your microbiome and your bifidobacteria, and now you're gonna get another virus and another virus." "Knowing what I know today, which is once you kill your microbiome, it takes years to recover."

Video Saved From X

reSee.it Video Transcript AI Summary
We need studies where people test their stools to see if long-term vitamin C improves bifidobacteria. To advance microbiome research, protocols need to be done properly. A clinician cannot recommend different vitamin C products from different stores because of variations in supervision. Selling a specific product ensures consistency, avoiding comparisons between different vitamins. Advancing this research is challenging because natural substances like vitamin C, vitamin D, and naturally occurring microbes cannot be patented. Patenting requires fabricating or modifying something to be new and novel. The speaker realized that forces are trying to stop innovations, despite a clinician's role to help patients with informed consent.

Video Saved From X

reSee.it Video Transcript AI Summary
It is nearly impossible to publish data that goes against the national public health narrative, preventing doctors from finding solutions. The speaker has conducted clinical trials for pharmaceutical companies, including vaccine studies, and has brought vaccines and other drugs to market. Some drugs never made it to market because they killed people. Clinical trial guidelines ensure safe drugs, but these guidelines were not followed during the pandemic, affecting everyone. COVID should have been a time for doctors to unite, but interference with research occurred. Science evolves through experiments, skepticism, and an open mind. Challenging current knowledge must be allowed to move science forward, but what the speaker witnessed during the pandemic was not science.

Video Saved From X

reSee.it Video Transcript AI Summary
" I'm a big believer of vitamin c. " "This doesn't mean it's going to work for everyone and we're not making any claims. " "There is definitely something about vitamin C through the years that have said to people, wait, vitamin C is pretty safe. " "But then we looked at the in vitro studies and that's how they grow the bitter bacteria. " "In vitro studies of vitamin C effect on the microbiome, you actually see increased Bifidobacteria with in vitro. " "So we just proved on a human clinical model what the in vitro model did. " "I'm on this big push of increasing the betrobacteria. " "That's my science... my vision. " "Are antibiotics good? Are they good long term? " "Now we're in the world of biologics. What are biologics doing to the microbiome? " "Maybe all disease starts with lots of bifidobacteria. " "As I'm improving the benefit of bacteria, I see improvement in the disease clinically as a physician."

Video Saved From X

reSee.it Video Transcript AI Summary
"in New Jersey, the rate of autism is one in thirty three, and we we are seeing a depletion of the microbiome." "New Jersey, one in thirty three." "one in ten thousand." "What happens in thirty years from now? Is it gonna be one in one?" "will there be a child born in this country that doesn't have autism?" "the disappearing microbes that I like to call the bifidobacteria disappearance." "I I told you at the beginning, bifidobacteria is important in helping us break down sugars." "What happens when it disappears? Right?" "You're going to have increased MECFS, right? Because they're tired." "MECFS have lots of bifidobacteria."

Video Saved From X

reSee.it Video Transcript AI Summary
Biologics for Crohn's disease are 'a great product to stop Crohn's disease, to decrease inflammation, but you have to keep taking it on a monthly basis. For the rest of your life?' The speaker argues, 'So basically you're not fixing the problem, you're just suppressing the inflammation.' The core issue is to 'find the reason why this happened to begin with,' but 'we've kinda stepped away from' the old approach: 'There used to be a time where we would do a whole workup on patients with Crohn's disease. You know is it tuberculosis? Is it, you know, is it a parasite, right, that's causing, Crohn's disease? Is it medications that they're taking?' And now, when symptoms arise, 'let's put them on a biologic.' So 'we're basically putting them on medications' that remind the patient they have Crohn's, affecting mental status, freedom, and travel: 'What does that do to your mental status? ... What does that do to your freedom to go travel?' Biologics are 'great for the moment' to decrease suffering, but when we have something else that could fix the problem once and for all, we need to start looking at that.

Video Saved From X

reSee.it Video Transcript AI Summary
"When fecal transplant showed more than, you know, improving C." "And one of my patients with Alzheimer's started remembering his daughter's date of birth, I said, what did I do? I just changed the microbiome." "I used the wife's microbiome to the husband." "It wasn't about pushing stools for Alzheimer's, but what was causing Alzheimer's? What microbes was the culprit?" "What microbes could suppress that microbe That's the culprit." "Babies have a lot of bifidobacteria, this important microbe that helps us decompose sugar." "And we saw a lot of Bifidobacteria in newborns." "There is obviously a consensus in the medical field because there's a lot of gynecologists now that are using the secretions from the vagina of the mom and smearing it on the baby that is born with C section to just make them healthier in a way."

Video Saved From X

reSee.it Video Transcript AI Summary
"I did a case where I did fecal transplant on a patient with Alzheimer's, and he could remember his daughter's date of birth six months after the procedure. So when I changed his microbiome, his poop in his colon, and gave him his wife's microbiome, who was super with it, started remembering things. So, when we start looking, and we're actually publishing stuff at ACG, because the deadline's today actually to publish for ACG American So, College of we have six abstracts coming up, and so we're showing the data on Alzheimer's, autism, long haulers. So, can't say vaccine injured because then it's not gonna be, you know, it's too controversial. So we have to stay within the but here's the problem. It should not be controversial. In order to advance science, in order to advance medicine, we need to be, better. We need to be better at listening"

Video Saved From X

reSee.it Video Transcript AI Summary
"everybody is different." "We all have a fingerprint of our microbiome." "families are different." "the mom with triplets had an overgrowth of a certain group of microbes and the triplets, two of the triplets didn't have that microbe, but the one with autism had twice the amount of microbes that the mom had." "Engraftment determines success of a fecal transplant." "The kid started speaking, verbalizing." "We discovered that those people that had severe COVID had zero Bifidobacteria." "autistic kids have loss of bifidobacteria." "two identical twins, same exact microbes disappeared after nine months, and the Bifidobacteria goes up." "these kids are verbalizing, they're reading, they're counting." "Restoring the microbiome, saving the Bif, improving the bifidobacteria, and the kids are verbalizing." "this is a new revelation." "And I think it's going to be one of the biggest discoveries of this century in my opinion."

Video Saved From X

reSee.it Video Transcript AI Summary
"If you look at kids if you look at patients with anxiety, okay, and you because ADHD, anxiety, similar, pattern in the microbiome anyways. So if you look at patients with anxiety, and now I'm taking my anxious patient, and I see a signature microbiome. Some microbes are overgrown, some microbes are low, and what I'm gonna do is I'm basically gonna give that patient a drug. That drug is blunting here the anxiety. Right?" "But it doesn't fix the microbiome." "You have a signature microbiome for anxiety." "Well, the drugs are great because they're working up here." "They're not working at the gut level. So this the anxiety problem is still there." "Do you think people who have ADHD don't have ADHD and they actually just have anxiety?" "I think people with ADHD are lacking microbes. That's what I think." "And the medication doesn't help at all?" "I I think it probably cuts down the symptoms, but I don't think it fix The root." "which is the the business model of most drugs, by the way."

Video Saved From X

reSee.it Video Transcript AI Summary
The probiotic industry understands the loss of bifidobacterium in cancer and aging populations, but cannot claim probiotics improve longevity due to FDA regulations requiring clinical trials. Doctors also face scrutiny for promoting products without sufficient data. The speaker conducts clinical trials, involving the FDA when bringing products to market, such as ivermectin, doxycycline, and zinc for COVID. Data showed no deaths during treatment, suggesting its effectiveness. Despite a product's market approval with a 20% success rate, the speaker emphasizes the need to address the remaining 80% of patients. Innovation and discussion among doctors are crucial, but social media is now essential for educating doctors and the public due to the high cost of publishing data.

Video Saved From X

reSee.it Video Transcript AI Summary
"My job, I know my job, my job is to wake up humanity to the microbiome and the fact that humanity is going extinct." "look in 1970, the rate of autism was one in ten thousand." "Now it's one in thirty in some areas of the country. California, one in twelve point five boys have autism." "twenty five percent of newborns are born with adequate levels of good bacteria." "out of 4,000 stool samples, less than five percent have bifidobacteria, which is an important microbe that helps us break down sugars." "So, you know, what happens when one in one kid has autism? What happens when there's no more bifidobacteria on the planet because we've destroyed it all? We stop living. That's it."

Video Saved From X

reSee.it Video Transcript AI Summary
Out of a thousand samples analyzed in the last year, less than 5% had bifidobacteria, and one out of a thousand stool samples had lactobacillus. Both are believed to be very important microbes. The speaker poses the question of what happens when Bifidobacteria and lactobacillus disappear. They claim you can't absorb sugar or calcium, and asks what happens to the Krebs cycle and humanity. They suggest the loss of bifida bacteria may be linked to chronic disease.

Video Saved From X

reSee.it Video Transcript AI Summary
Everything that happens regarding illness is reframed as an infection. In the pediatric world, 'anytime someone gets sick, there's a bug going around,' and 'anytime someone is sick, you have an infection, you need a medication.' 'there's a huge controversy in the world right now, and it is volatile, and that issue is around viruses.' 'I remember learning in medical school that viruses are inert, that they're not real organisms.' 'There is no such thing as an isolated virus.' 'No one has ever seen a viral particle.' 'We have created a pictorial of a viral particle.' 'But we have never truly seen a virus or ever seen a virus in action.' 'I had a public discussion with doctor McCullough.'

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0: You ask whether there has been any success or attribution of improvement to addressing SIBO, which has become a chronic condition that is usually treated with antibiotics. Speaker 1: This is like a band-aid approach. I always think that science serves best with the tools available at any given time. When a new technology arrives that provides another tool, science advances, and what we believed to be true yesterday may no longer hold. At this juncture, what gastroenterology knows is antibiotics, because the focus is on killing the microbe. I am coming from a more controversial angle in the sense that I’m proposing a shift: stop killing, start building. What we have noticed when testing patients with SIBO is that if you fix the dysbiosis, the colonic dysbiosis, you’re fixing the SIBO. In my humble opinion, SIBO starts with gut dysbiosis and leaky gut. For those who aren’t familiar with the term, gut dysbiosis in layman’s terms is essentially the balance, or rather the imbalance, between the good and the bad microbes as far as we know. Speaker 0: So the key idea being discussed is that the current standard approach to SIBO—antibiotics aimed at eliminating the microbial population—may be limited because it treats the symptom (microbial overgrowth) rather than addressing the underlying ecosystem imbalance in the gut. The speaker emphasizes that improvements in SIBO may be achieved by first correcting the gut’s microbial balance (dysbiosis) and the integrity of the gut lining (leaky gut), rather than solely aiming to kill microbes. Speaker 1: The implication is that the treatment paradigm could shift from a primary emphasis on antimicrobial eradication to strategies that restore a healthy microbiome and gut barrier function, with the assertion that such restoration could reduce or resolve SIBO. This view frames dysbiosis as the starting point for SIBO, suggesting that addressing microbial balance and gut permeability could have a direct impact on the condition. Speaker 0: In summary, the dialogue contrasts the conventional antibiotic-focused approach with a proposed one that prioritizes rebuilding the gut’s microbial ecosystem and improving gut barrier health as a means to address SIBO at its roots.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 notes a contrast: people are afraid of parasites, yet caterpillars are worms too and nobody is afraid of them. They suggest this is something to think about. They state that the body makes parasites, and when there are too many heavy metals in the body, the body will make worms. Therefore, they argue, one should be afraid of the metals put into the body—like pesticides, vaccines, toxins, and related substances. They claim that people will take dewormers made by Rockefeller-founded pharmaceutical companies to destroy the worms, and question what these dewormers actually do, asserting that they destroy your own body. They remark that it’s wild to think about these things and that the dewormers’ origin isn’t commonly known, mentioning Rockefeller and “Great Public school.” The speaker contends that Rockefeller-created synthetic dewormers are sold as poison to destroy worms, while making the worm seem dangerous when, in reality, it’s one’s own habits being the issue. They then reference doctor Joel Weinstock, claiming he was healing diseases with parasites, adding this as something to think about.

Video Saved From X

reSee.it Video Transcript AI Summary
You've had success in restoring brains and bodies with autism, including an N of one with a fecal transplant. There’s multiple ways with Crohn's disease, and some patients "have to stay on biologics," while "some patients with Crohn's disease actually are not Crohn's disease." "It's an infectious process," but "some people ... it's a genetic process," and many patients have "a lack of, diversity" and "lack of bifidobacteria" at the start. The approach is multifactorial, exploring whether Crohn's is from "mycobacterial paratuberculosis," "Yersinia enterolitica," or "E. Coli," among other factors. Alzheimer's research is at "an n of one," seeking a formula to "restore the gut" for those patients. In diabetes, with John Welborn, they aim to study the microbiome of type one, noting "improvement ... but it's not enough to get them off the insulin," exploring potential pancreatic microbiome issues and dysbiosis; "still far, far from answers ... but promising."

Video Saved From X

reSee.it Video Transcript AI Summary
Here's the thing I learned about the microbiome, which is very important. You can live with a sterile gut. And this is why the whole naturopath world sees improvement in what you do with everything you do. You could live in a sterile world, right, where you kill off all the microbes. But here's the problem. You go from that sterile world to India where you're walking barefoot and you're catching a parasite going to your foot to your brain or to your pancreas, and then next thing you know, you wake up one morning and you're like cancer. You can live in the sterile environment and you're perfectly fine in that sterile environment, but then once you go to the streets, you're gonna get sick because you're not exposed to all these microbes. And you can live in a diverse environment where you're protected with the environment.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 1 discusses probiotics and the current state of microbiome science: taking random probiotics may be questionable because the technology of the microbiome is not FDA-approved yet. The reason is that there are many bacteria in the microbiome and we don’t know what they are, what they do, whether they’re good or bad. For example, blotia and Rosaburia are poorly understood; 90% of GI colleagues don’t know blotia is a microbe, and 90% don’t know there’s such a thing as Rosaburia. Historically trained on Klebsiella pneumoniae, E. coli, Salmonella, C. difficile, Clostridium perfringens, but not on nonpathogenic microbes. The question remains: is blotia a good bug or a bad bug, and who has too high or too low levels? This represents the abyss of the microbiome and is still research, not consumer product or standard medical practice. Speaker 1 explains that doctors cannot be told to use a new stool test or to start using microbiome data broadly until researchers reproduce findings and doctors see the data for themselves. The idea is that oncologists may notice correlations, such as loss of bifidobacteria in invasive cancer, and observe improvements in cancer alongside bifidobacteria, which could influence acceptance of the gut-brain or microbiome link. However, such observations need replication to move from incidental findings to established conclusions. An example given is Colleen Kelly at Brown University, who published two cases of alopecia areata with C. difficile where hair grew back after fecal transplant. The question is whether fecal transplant for alopecia areata is valid; however, an academic center trying to reproduce the data could not. The speaker suggests uncertainty about whether a specific microbe caused hair regrowth or if exposure during treatment led to it. Until data are reproduced, no one can claim alopecia areata is improved by fecal transplant or microbiota transplant. Concluding guidance: if you’re healthy, keep doing what you’re doing and do nothing else; if you’re not healthy and have multiple diseases and you’ve tried a probiotic, if it works, continue, but if it doesn’t work, then it’s probably not a great probiotic. The overarching theme is careful interpretation, replication, and recognition that microbiome science is still evolving and not yet ready for universal clinical application.

Video Saved From X

reSee.it Video Transcript AI Summary
Out of a thousand samples analyzed in the last year, less than 5% had bifidobacteria, and one out of a thousand stool samples had lactobacillus. Both are considered very important microbes. The speaker asks what happens when Bifidobacteria and lactobacillus disappear, claiming that you can't absorb sugar or calcium, and questioning what happens to the Krebs cycle and humanity. The speaker suggests that the loss of bifida bacteria may be linked to chronic disease.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker challenges common beliefs about parasites and contagion. They assert that fear campaigns on social media about parasites jumping from person to person have not been proven; no studies have demonstrated transmission of parasites between individuals. Instead, they claim that when an animal is loaded with heavy metals, it will grow parasites in its body to eat the metals, and that parasites are an indicator of heavy metals. The speaker states that there are about 5,000 studies on PubMed supporting this point and invites listeners to search Google for these studies. They argue that science has “figured” this out, but claim that the consequence is that people are sold dewormers, which the speaker characterizes as poison.

Video Saved From X

reSee.it Video Transcript AI Summary
But I think there's you know, what's beautiful now because so many doctors are stepping up and seeing something and talking about something, I'm not saying that's the right thing. 'Is ivermectin improving cancer? Certainly some doctors have seen it.' 'So is that the way we is it improving for everybody? What is it in ivermectin that improves the microbiome of certain people and not in others? What is it in ivermectin that helps certain cancers and not others? Right? So we really need to be better to say, okay, look, I'm courageous enough to add ivermectin to my protocol of the chemo or the bio or the immunotherapy that I'm giving or maybe I don't.' 'And maybe at least I look at the microbiome. I look at the microbiome on what is believed right now, you know, a a good look at it.'

Video Saved From X

reSee.it Video Transcript AI Summary
- "a great product to stop Crohn's disease, to decrease inflammation, but you have to keep taking it on a monthly basis." - "So basically you're not fixing the problem, you're just suppressing the inflammation." - "The problem is find the reason why this happened to begin with." - "There used to be a time where we would do a whole workup on patients with Crohn's disease." - "And now we've kinda stepped away from that." - "We're not fixing the problem that stops these people from having Crohn's to begin with. We're basically putting them on medications." - "The problem with the medication is that now the kid is being reminded that he has Crohn's disease every single month." - "So he's identified."

Video Saved From X

reSee.it Video Transcript AI Summary
"My page is now censored like there's less people in here and there's less people seeing my page for talking about eating organic unpasteurized blue cheese." "So people used to eat a lot of blue cheese, but it wasn't until they were injected with penicillin till they stopped eating as much blue cheese as they once did." "And you can kinda figure out where the peanut allergy came from, the latex allergy, the shellfish allergy, all these different allergies, they're coming from the injections." "And guess who sells the EpiPen? The same people who created those injections that they were putting into the people." "You can kinda see what the purpose is of that. of that. You control the people because you inject them when they're young so that they can't eat things or have them go into their body later on in life."

The Rich Roll Podcast

#1 PROBIOTICS EXPERT: Using Microbes To OPTIMIZE Your Health | Dr. Gregor Reid
Guests: Gregor Reid
reSee.it Podcast Summary
Dr. Gregor Reid emphasizes the importance of integrating nutrition, microbiome knowledge, and probiotics into medical education. He helped define probiotics as live microorganisms that confer health benefits when administered in adequate amounts. Reid discusses the misconceptions surrounding probiotics, the need for rigorous human studies, and the challenges consumers face in distinguishing effective products from ineffective ones. He highlights the potential of probiotics to reduce antibiotic use and improve overall health, particularly in preventing conditions like urinary tract infections and necrotizing enterocolitis in premature infants. Reid shares his frustrations with the medical establishment's slow acceptance of probiotics, despite evidence supporting their benefits. He advocates for more funding and research into the microbiome, suggesting that understanding microbial interactions could lead to breakthroughs in treating various health issues. He also points out the environmental implications of microbiomes, discussing how beneficial microbes could help address ecological challenges, such as coral reef decline and honeybee population issues. The conversation touches on the commodification of probiotics, with many products on the market lacking scientific backing. Reid stresses the need for consumers to be informed and for regulatory bodies to establish clear guidelines for probiotic products. He believes that the future of probiotics lies in targeted applications, potentially in combination with pharmaceuticals, and calls for a collaborative approach among scientists, healthcare professionals, and industry to advance this field. Reid encourages young scientists to pursue innovative ideas and emphasizes the importance of resilience in the face of skepticism. He shares personal anecdotes about his journey in microbiology and the impact of his travels on his perspective. Ultimately, he advocates for a paradigm shift in how society views and utilizes microbes, urging a more holistic approach to health that includes the microbiome.
View Full Interactive Feed